ATE443755T1 - Erkennung, vorbeugung und behandlung papillomatöser digitaler dermatitis - Google Patents

Erkennung, vorbeugung und behandlung papillomatöser digitaler dermatitis

Info

Publication number
ATE443755T1
ATE443755T1 AT97935070T AT97935070T ATE443755T1 AT E443755 T1 ATE443755 T1 AT E443755T1 AT 97935070 T AT97935070 T AT 97935070T AT 97935070 T AT97935070 T AT 97935070T AT E443755 T1 ATE443755 T1 AT E443755T1
Authority
AT
Austria
Prior art keywords
prevention
detection
treatment
digital dermatitis
papillomatous digital
Prior art date
Application number
AT97935070T
Other languages
English (en)
Inventor
Dale Wallis
James L Wallis
Original Assignee
Dale Wallis
James L Wallis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dale Wallis, James L Wallis filed Critical Dale Wallis
Application granted granted Critical
Publication of ATE443755T1 publication Critical patent/ATE443755T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
AT97935070T 1996-08-01 1997-07-31 Erkennung, vorbeugung und behandlung papillomatöser digitaler dermatitis ATE443755T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2291596P 1996-08-01 1996-08-01
PCT/US1997/012861 WO1998005755A1 (en) 1996-08-01 1997-07-31 Detection, prevention and treatment of papillomatous digital dermatitis

Publications (1)

Publication Number Publication Date
ATE443755T1 true ATE443755T1 (de) 2009-10-15

Family

ID=21812090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97935070T ATE443755T1 (de) 1996-08-01 1997-07-31 Erkennung, vorbeugung und behandlung papillomatöser digitaler dermatitis

Country Status (19)

Country Link
US (2) US6162429A (de)
EP (1) EP0863981B1 (de)
JP (1) JP2000500027A (de)
KR (1) KR19990063786A (de)
CN (1) CN1198185A (de)
AT (1) ATE443755T1 (de)
AU (1) AU732317B2 (de)
BR (1) BR9706543A (de)
CA (1) CA2233570C (de)
DE (1) DE69739592D1 (de)
DK (1) DK0863981T3 (de)
EA (2) EA004873B1 (de)
ES (1) ES2336285T3 (de)
IL (1) IL123922A (de)
MX (1) MX9802543A (de)
NZ (1) NZ330050A (de)
PT (1) PT863981E (de)
TR (1) TR199800597T1 (de)
WO (1) WO1998005755A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241992B1 (en) * 1997-09-08 2001-06-05 University Technologies International, Inc. Bovine footrot treatment and prevention
US6667040B2 (en) 1997-09-08 2003-12-23 University Technologies International, Inc. Bovine footrot treatment and prevention
US6287575B1 (en) * 1997-10-03 2001-09-11 The Regents Of The University Of California Vaccine against papillomatous digital dermatitis (PDD)
US7097861B1 (en) 2003-02-07 2006-08-29 Jones-Hamilton Co. Method of treating livestock footbath solutions
US8703104B2 (en) * 2007-10-25 2014-04-22 Ecolab Usa Inc Use of metal astringents for the treatment of hairy heel warts
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
US10022458B2 (en) 2015-03-05 2018-07-17 Iowa State University Research Foundation, Inc. Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175516A (en) * 1966-04-15 1969-12-23 Science Union & Cie New Phenyl-Aminopropane Derivatives and Preparations Containing them
US3673205A (en) * 1970-03-25 1972-06-27 American Cyanamid Co 6-(m-AMINO AND SUBSTITUTED-AMINO PHENYL)-2,3,5,6-TETRAHYDRO{8 2,1-b{9 THIAZOLES AND METHOD OF USE
US4029763A (en) 1974-08-05 1977-06-14 Mount Sinai School Of Medicine Of The City University Of New York Influenza vaccine containing purified neuraminidase antigen and method of using the same
DE2930706A1 (de) * 1979-07-28 1981-02-05 Medac Klinische Spezialpraep Verfahren zum nachweis von erregerspezifischen antikoerpern
JPS6067474A (ja) * 1983-09-24 1985-04-17 Wakamoto Pharmaceut Co Ltd 新規な１，３，４−チアジアゾ−ル誘導体及びそれを有効成分とする抗潰瘍剤
US4746613A (en) * 1984-03-02 1988-05-24 Wichmann Robert W Poultry diseases bacterin preparation
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
US5630379A (en) * 1996-02-12 1997-05-20 Ssi Corporation Electrically controlled spraying device for cleaning and treating animals
US6287575B1 (en) * 1997-10-03 2001-09-11 The Regents Of The University Of California Vaccine against papillomatous digital dermatitis (PDD)

Also Published As

Publication number Publication date
EP0863981A4 (de) 2002-09-18
PT863981E (pt) 2010-01-04
CA2233570A1 (en) 1998-02-12
DK0863981T3 (da) 2010-02-01
EP0863981B1 (de) 2009-09-23
TR199800597T1 (xx) 1998-06-22
EP0863981A1 (de) 1998-09-16
EA199800243A1 (ru) 1998-10-29
CA2233570C (en) 2013-02-19
US6162429A (en) 2000-12-19
AU3809997A (en) 1998-02-25
AU732317B2 (en) 2001-04-12
WO1998005755A1 (en) 1998-02-12
US6884412B1 (en) 2005-04-26
MX9802543A (es) 1998-11-30
ES2336285T3 (es) 2010-04-09
DE69739592D1 (de) 2009-11-05
IL123922A (en) 2005-07-25
EA002181B1 (ru) 2002-02-28
NZ330050A (en) 2000-01-28
BR9706543A (pt) 1999-12-28
KR19990063786A (ko) 1999-07-26
CN1198185A (zh) 1998-11-04
EA004873B1 (ru) 2004-08-26
EA200001056A1 (ru) 2001-04-23
JP2000500027A (ja) 2000-01-11

Similar Documents

Publication Publication Date Title
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
ATE290391T1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
MXPA02010826A (es) Compuestos y metodos para el tratamiento y la prevencion de infeccion bacteriana.
DE69841437D1 (de) Bakterielle impfstoffe, enthaltend auxotrophe attenuierte listerienstämme, welche heterologe antigene exprimieren
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
DK0986314T3 (da) Probiotisk mælkesyrebakterie til behandling af bakterielle infektioner associeret med SIDS
CA2408537A1 (en) Treating irritable bowel syndrome or disease
HU9502160D0 (en) Pharmaceutical formulation of cefaclor
DE69739592D1 (de) Erkennung, vorbeugung und behandlung papillomatöser digitaler dermatitis
NO20011537L (no) Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes
EP1303300A4 (de) Zusammensetzungen und methoden zur behandlung von candidosen
FI941552A0 (fi) Gamma-INF:n käyttö infektioiden hoitoon siirrännäisten saajilla
ATE307575T1 (de) Zusammensetzung geeignet als nahrungsmittelzusatz und zur anwendung bei darmerkrankungen sowie bei veränderter darmflora
ATE313628T1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
MD980129A (en) Antiherpetic remedy
MD1305B2 (en) Nutrient medium for selective separation of the Enterobacteriaceae family representatives
MD20010055A (ro) Preparat microbian sanogenic pentru profilaxia şi tratamentul disbacteriozei intestinale
MX9708385A (es) Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0863981

Country of ref document: EP

REN Ceased due to non-payment of the annual fee